Fig. 1 · Structure

Documents & Downloads

Cyclocytidine

Cat. No. A11683 CAS 31698-14-3

In Stock

Free Aliquoting for Your Order

Tell us your preferred amount per vial. We’ll confirm the options.

Cyclocytidine Research Summary

This section summarizes 2 in vitro studies of Cyclocytidine from 1 published reference. In vitro models include HepAD38 cells.

Cyclocytidine In Vitro Studies

In HepAD38 cells, Cyclocytidine at concentrations over 20 µM produced over 50% cytotoxicity after 2d treatment in an MTT cell viability assay. At 20 µM, Cyclocytidine-treated HepAD38 cells exhibited about 50% cell viability after 4 days treatment, as measured by an MTT assay. [1]

Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.

Cytotoxicity in HepAD38 Cells

Cell-based study · HepAD38 cells [1]

HepAD38 cells treated with Cyclocytidine at concentrations over 20 µM exhibited over 50% cytotoxicity after 2d treatment, as measured by the MTT cell viability assay.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
MTT cell viability assaycytotoxicity 2d treatment, concentrations over the 20 µM: over 50% cytotoxicity[1]

Literature-Reported Treatment Conditions

Treatment concentration
concentrations over the 20 µM
Exposure duration
2d treatment
Method
cultured in 6-cm culture dish with different amounts of cyclocytidine HCl
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Cyclocytidine

Evidence for Cyclocytidine as the hydrochloride form reported in the paper, not the free base/neutral form supplied as A11683; no salt equivalence, dose conversion or lot validation.

Material and Methods > Cell culture and cyclocytidine HCl treatment (S3); Material and Methods > MTT assay (S6, S7, S10); Results > Cytotoxicity of cyclocytidine HCl on HepAD38 cells (S27)

MTT cell viability assay: MTT cell viability assay; comparator: The same volume of dimethyl sulfoxide (DMSO) was added to cells as a mock treatment. — Results > Cytotoxicity of cyclocytidine HCl on HepAD38 cells (S27)

Cell Viability in HepAD38 Cells

Cell-based study · HepAD38 cells [1]

HepAD38 cells treated with Cyclocytidine at 20 µM exhibited about 50% cell viability after 4 days treatment, as measured by an MTT assay.

Measured endpoints — not treatment concentrations
EndpointReported resultReference
cell viability was measured using a MTT assaycell viability about 50% of cell viability[1]

Literature-Reported Treatment Conditions

Treatment concentration
20 µM
Exposure duration
day 2 and day 4
Method
cultured in 6-cm culture dish with different amounts of cyclocytidine HCl
Reported limits
Not stated in the sentences used: vehicle.
Methods and source locations

Compound reported in the paper: Cyclocytidine

Evidence for Cyclocytidine as the hydrochloride form reported in the paper, not the free base/neutral form supplied as A11683; no salt equivalence, dose conversion or lot validation.

Material and Methods > Cell culture and cyclocytidine HCl treatment (S3); Material and Methods > MTT assay (S6, S7, S10); Results > Cytotoxicity of cyclocytidine HCl on HepAD38 cells (S29, S30); Figure 1 legend (S41)

cell viability was measured using a MTT assay: cell viability was measured using a MTT assay; comparator: The same volume of dimethyl sulfoxide (DMSO) was added to cells as a mock treatment. — Results > Cytotoxicity of cyclocytidine HCl on HepAD38 cells (S30); Figure 1 legend (S41)

Specifications

Manufacturer Adooq Bioscience
CAS Number 31698-14-3
Formula C9H11N3O4
Molecular Weight 225.2
SMILES
C1=CN2[C@H]3[C@H]([C@@H]([C@H](O3)CO)O)OC2=NC1=N

Storage & Solubility

In Vitro Solubility

Reported Solubility

No reported solubility data are available for this product.

Preparing Stock Solutions

Stock preparation is unavailable for this product molecular weight.

Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.

Storage

Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.

Cyclocytidine Research References

  1. [1] Wang X, Xiao Y, Cui Z, et al. Cyclocytidine hydrochloride inhibits the synthesis of relaxed circular DNA of hepatitis B virus. PeerJ (2022). PMID: 35846878 DOI: 10.7717/peerj.13719 Source material

Added to your cart

View Cart Checkout
Loading...